American International Group, Inc. Cytom X Therapeutics, Inc. Transaction History

American International Group, Inc.

$8.5 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.53 - $2.89 $49,266 - $93,058	-32,200 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$2.67 - $4.68 $6,052 - $10,609	-2,267 Reduced 6.58%	32,200 $86,000
Q4 2021 Feb 11, 2022	SELL	$3.87 - $7.39 $3,989 - $7,619	-1,031 Reduced 2.9%	34,467 $149,000
Q3 2021 Nov 12, 2021	SELL	$4.32 - $6.43 $3,646 - $5,426	-844 Reduced 2.32%	35,498 $181,000
Q2 2021 Aug 13, 2021	BUY	$6.33 - $9.91 $2,804 - $4,390	443 Added 1.23%	36,342 $230,000
Q1 2021 May 07, 2021	BUY	$6.6 - $9.0 $63,723 - $86,895	9,655 Added 36.79%	35,899 $277,000
Q4 2020 Feb 12, 2021	SELL	$6.47 - $7.9 $4,865 - $5,940	-752 Reduced 2.79%	26,244 $172,000
Q3 2020 Nov 04, 2020	SELL	$6.55 - $8.83 $4,028 - $5,430	-615 Reduced 2.23%	26,996 $180,000
Q2 2020 Aug 12, 2020	BUY	$7.4 - $14.64 $7,081 - $14,010	957 Added 3.59%	27,611 $230,000
Q1 2020 May 04, 2020	SELL	$3.61 - $8.6 $5,563 - $13,252	-1,541 Reduced 5.47%	26,654 $204,000
Q4 2019 Feb 05, 2020	SELL	$5.17 - $8.91 $1,230 - $2,120	-238 Reduced 0.84%	28,195 $234,000
Q3 2019 Nov 08, 2019	SELL	$7.38 - $12.25 $1,461 - $2,425	-198 Reduced 0.69%	28,433 $210,000
Q2 2019 Aug 13, 2019	BUY	$9.35 - $11.41 $2,318 - $2,829	248 Added 0.87%	28,631 $321,000
Q1 2019 May 06, 2019	SELL	$9.5 - $19.16 $8,740 - $17,627	-920 Reduced 3.14%	28,383 $305,000
Q4 2018 Feb 13, 2019	SELL	$12.69 - $18.61 $2,867 - $4,205	-226 Reduced 0.77%	29,303 $442,000
Q3 2018 Nov 09, 2018	BUY	$18.04 - $26.41 $79,502 - $116,388	4,407 Added 17.54%	29,529 $546,000
Q2 2018 Aug 08, 2018	BUY	$21.38 - $29.68 $140,060 - $194,433	6,551 Added 35.28%	25,122 $574,000
Q1 2018 May 07, 2018	SELL	$21.76 - $34.22 $21,716 - $34,151	-998 Reduced 5.1%	18,571 $528,000
Q4 2017 Feb 09, 2018	BUY	$19.0 - $23.09 $1,748 - $2,124	92 Added 0.47%	19,569 $413,000
Q3 2017 Nov 09, 2017	BUY	$13.53 - $18.17 $263,523 - $353,897	19,477	19,477 $354,000

Others Institutions Holding CTMX

# of Institutions

Shares Held

50.7M

Call Options Held

112K

Put Options Held

8.3K

Tang Capital Management LLC San Diego, CA

7.81M
Shares

$8.98 Million
0.79% of portfolio
Bvf Inc San Francisco, CA

5.23M
Shares

$6.01 Million
0.2% of portfolio
Vanguard Group Inc Valley Forge, PA

5.16M
Shares

$5.94 Million
0.0% of portfolio
Janus Henderson Group PLC London, X0

4.81M
Shares

$5.53 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

3.1M
Shares

$3.57 Million
0.01% of portfolio

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $75.8M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account